presumed leiomyomas 的子宫粉碎术:ACOG 委员会意见第822号摘要
美国妇产科医师学会(ACOG)发布委员会意见,讨论 presumed leiomyomas 行子宫或肌瘤粉碎术时隐匿性子宮平滑肌肉瘤播散风险。指出术前无法可靠诊断平滑肌肉瘤,粉碎恶性肿廇为禁忌,应与患者共享决策并充分知情同意,权衡微创粉碎与开腹手术的利弊。
要点
- 粉碎术前应评估子宮体恶性肿廇风险,但平滑肌肉瘤术前无法可靠诊断。
- 恶性肿廇粉碎为禁忌,隐匿性平滑肌肉瘤粉碎可能播散并恶化预后。
- 开腹子宮切除或肌瘤剔除可降低癌细胞播散风险,但比微创术式并发症更多。
核心结论
- 对 presumed leiomyomas 行粉碎术前应评估子宮体恶性肿廇风险,并与患者共享决策、充分知情同意。
研究设计与样本
- ACOG 委员会意见第822号摘要,基于现有证据综述粉碎术相关风险与获益。
主要发现
- 使用动力粉碎器行子宮或肌瘤粉碎时,隐匿性子宮平滑肌肉瘤可能播散。
- 平滑肌肉瘤术前无法可靠诊断,故 presumed leiomyoma 患者存在恶性肿廇被粉碎播散的风险。
- 开腹子宮切除或肌瘤剔除可降低未确诊平滑肌肉瘤癌细胞播散几率,但较微创术式并发症增加。
关键数值与推荐
- 恶性肿廇粉碎为禁忌。
- 粉碎术前应评估患者子宮体恶性肿廇风险是否增加。
- 应与患者共享决策并知情同意,说明各术式风险获益、粉碎风险获益及替代方案。
临床怎么用
- 对 presumed leiomyomas 拟行粉碎术者,术前评估恶性风险并告知粉碎潜在肿瘤播散风险。
- 与患者共享决策,个体化选择微创粉碎或开腹手术,并充分知情同意。
局限性
- 平滑肌肉瘤术前无法可靠诊断,故粉碎前恶性肿廇筛查手段有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Morcellation is a surgical technique used to reduce the size of the uterus or myomas by creating smaller pieces to allow the tissue to be removed through small incisions or with laparoscopic instruments. Open (uncontained) morcellation of the uterus and myomas has been scrutinized because of the possible spread of an unsuspected leiomyosarcoma while using a power morcellator during a hysterectomy or myomectomy for presumed symptomatic uterine leiomyomas. Before considering morcellation of the uterus, a woman should be evaluated to determine if she is at increased risk of malignancy of the uterine corpus. Morcellation of a malignancy is contraindicated and women should be evaluated preoperatively to identify malignancy. However, leiomyosarcoma cannot be reliably diagnosed preoperatively; thus, there is a risk that a woman with a presumed leiomyoma may have a malignancy that may be spread through morcellation, leading to a potentially worsened prognosis. Although an abdominal hysterectomy or myomectomy may reduce the chance of spreading cancer cells in women with undiagnosed leiomyosarcoma, it is associated with increased morbidity when compared with minimally invasive approaches. The obstetrician-gynecologist and patient should engage in shared decision making, including informed consent, explaining the risks and benefits of each approach to surgery for presumed leiomyomas, the risks and benefits of morcellation, and alternatives to morcellation.
引用
- Uterine Morcellation for Presumed Leiomyomas: ACOG Committee Opinion Summary, Number 822. Obstet Gynecol. 2021. PMID: 33595248. doi:10.1097/AOG.0000000000004292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。